CareLit · DOI-Nachweis · TumorDiagnostik & Therapie
Allogeneic HSCT in patients with MDS
DOI 10.1055/s-0034-1389177
Bibliografische Angaben
Nachweis in CareLit
Autor:innenU Platzbecker, A Giagounidis
ZeitschriftTumorDiagnostik & Therapie
Ausgabe10/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Still, allogeneic HSCT remains the only curative option for a small subset of medically fit patients with higher-risk MDS. Patient stratification for allogeneic HSCT is mainly based on MDS risk scores, age and comorbidities. In general, the earlier the transplantation takes place during the disease course the better the chances of long-term cure. On the other hand, patients with less advanced disease should not be e…
Zitieren
Zitierempfehlung
U Platzbecker, A Giagounidis (2014) Allogeneic HSCT in patients with MDS. TumorDiagnostik & Therapie (10). https://doi.org/10.1055/s-0034-1389177
Mit CareLit weiterarbeiten